Nation-Wide Analysis of Glaucoma Medication Prescription in Fiscal Year of 2019 in Japan.

ABSTRACT: To report the updated prescription trend of antiglaucoma medications, the dose-based prescription of a glaucoma medication in Japan in the fiscal year 2019 was aggregated by using the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) Open data. Of the 100 most frequently prescribed topical medications for outpatients from out-hospital pharmacies, 32 glaucoma medications were identified. This year, 150.8 million ml of glaucoma medications prescribed accounted for 12.3% of the total prescription dose (1.3 billion ml). The dose was the largest with prostaglandin FP_2α agonist (PGF_2α), followed by the fixed-dose combination (FDC) of β-blocker and carbonic anhydrase inhibitor (β + CAI) and α₂-agonist. Prescription doses peak

SUBMITTER: Tanito M 

PROVIDER: S-EPMC9224924 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature